Biomedical Engineering Reference
In-Depth Information
20. Neff MW, Robertson KR, Wong AK, Safra N, Broman KW, Slatkin M, Mealey KL, Ped-
ersen NC. 2004. Breed distribution and history of canine mdr1-1delta, a pharmacogenetic
mutation that marks the emergence of breeds from the collie lineage. Proc Natl Acad Sci
U S A 101:11725-11730.
21. Luker GD, Fracasso PM, Dobkin J, Piwnica-Worms D. 1997. Modulation of the multidrug
resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo. J Nucl Med
38:369-372.
22. Del Vecchio S, Zannetti A, Aloj L, Salvatore M. 2003. MIBI as prognostic factor in breast
cancer. J Nucl Med 47:46-50.
23. Sasongko L, Link JM, Muzi M, Mankoff DA, Yang XD, Collier AC, Shoner SC, Unadkat
JD. 2005. Imaging P-glycoprotein transport activity at the human blood-brain barrier
with positron emission tomography. Clin Pharmacol Ther 77:503-514.
24. Sharom FJ, Liu R, Qu Q, Romsicki Y. 2001. Exploring the structure and function of the
P-glycoprotein multidrug transporter using fluorescence spectroscopic tools. Seminars
Cell Dev Biol 12:257-266.
25. Sharom FJ, Yu X, Doige CA. 1993. Functional reconstitution of drug transport and
ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J Biol
Chem 268:24197-24202.
26. Sharom FJ, Yu X, DiDiodato G, Chu JWK. 1996. Synthetic hydrophobic peptides are
substrates for P-glycoprotein and stimulate drug transport. Biochem J 320:421-428.
27. Robert J, Jarry C. 2003. Multidrug resistance reversal agents. J Med Chem 46:4805-4817.
28. Schmitt L, Tampe R. 2002. Structure and mechanism of ABC transporters. Curr Opin
Struct Biol 12:754-760.
29. Jones PM, George AM. 2004. The ABC transporter structure and mechanism: perspectives
on recent research. Cell Mol Life Sci 61:682-699.
30. Loo TW, Clarke DM. 1995. Membrane topology of a cysteine-less mutant of human
P-glycoprotein. J Biol Chem 270:843-848.
31. Kast C, Canfield V, Levenson R, Gros P. 1996. Transmembrane organization of mouse
P-glycoprotein determined by epitope insertion and immunofluorescence. J Biol Chem
271:9240-9248.
32. Linton KJ, Higgins CF. 2002. P-glycoprotein misfolds in Escherichia coli : evidence
against alternating-topology models of the transport cycle. Mol Membr Biol 19:51-58.
33. Loo TW, Clarke DM. 1999. The transmembrane domains of the human multidrug re-
sistance P-glycoprotein are sufficient to mediate drug-binding and trafficking to the cell
surface. J Biol Chem 274:24759-24765.
34. Raviv Y, Pollard HB, Bruggemann EP, Pastan I, Gottesman MM. 1990. Photosensitized
labeling of a functional multidrug transporter in living drug-resistant tumor cells. J Biol
Chem 265:3975-3980.
35. Hopfner KP, Karcher A, Shin DS, Craig L, Arthur LM, Carney JP, Tainer JA. 2000.
Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-
strand break repair and the ABC-ATPase superfamily. Cell 101:789-800.
36. Locher KP, Lee AT, Rees DC. 2002. The E. coli BtuCD structure: a framework for ABC
transporter architecture and mechanism. Science 296:1091-1098.
37. Smith PC, Karpowich N, Millen L, Moody JE, Rosen J, Thomas PJ, Hunt JF. 2002. ATP
binding to the motor domain from an ABC transporter drives formation of a nucleotide
sandwich dimer. Mol Cell 10:139-149.
 
Search WWH ::




Custom Search